What is ICRweb?

What is ATLAS?

ATLAS (Asian clinical TriaLs network for cAncerS) is the international project which has been launched by the National Cancer Center Hospital Japan in 2020, funded by Japan Agency for Medical Research and Development (AMED).
The purpose of the ATLAS project is to establish a network for cancer clinical trials connecting ASEAN states, to generate high-quality clinical trial data for pharmaceutical approval, driving collaborative cancer drug development through both industry-sponsored and investigator-initiated clinical trials.
The project will improve oncology drug access in Asia, where available drugs are limited. Together with the firm establishment of cancer genomic medicine, drug development in collaboration across Asia will be promoted, thereby addressing Asia’s needs.
E-learning program provided in this ICRweb is one of the ATLAS project activities to build capacity for conducting high-quality clinical trials and to realize genomic medicine, for all clinical trial professionals around the world.

ATLAS project: Greetings from the Director of this project

Online courses:

  1. Cancer Genome-based Medicine Course
  2. ISO 15189 Accreditation Support Course
  3. Phase 1 Trial Development Course
  4. CRC Training Course
  5. ATLAS International Symposium

News

  • A lecture of Cancer Genome-based Medicine Course-The Practice in JAPAN and CRC Training Course was posted.
  • The two lectures of CRC Training Course have been posted.
  • A lecture of Cancer Genome-based Medicine Course and CRC Training Course was posted.
  • The 6 lectures of Cancer Genome-based Medicine Course have been posted.
  • We have posted a collection of recordings video from the ATLAS Symposium.
  • The 4 lectures of CRC Training Course have been posted.
  • We have released English version site.

Go to top